STOCK TITAN

[8-K] Renovaro Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Renovaro Inc. (Nasdaq: RENB) disclosed in an 8-K that it received a Nasdaq Listing Rule 5620(a) deficiency notice on 7 July 2025 for failing to hold its FY 2024 annual shareholder meeting within 12 months of the 30 June 2024 fiscal year-end.

The company has 45 calendar days to submit a remediation plan; if Nasdaq accepts it, Renovaro could receive an extension until 29 December 2025 to regain compliance. Until then, the stock will continue trading on Nasdaq. Failure to file an acceptable plan or to hold the meeting by the deadline could lead to delisting.

Management states it is “working diligently” to prepare the plan and schedule the meeting “as soon as practicable.” No other operational or financial metrics were disclosed.

Renovaro Inc. (Nasdaq: RENB) ha comunicato tramite un modulo 8-K di aver ricevuto il notifica di carenza secondo la Regola di Quotazione Nasdaq 5620(a) il 7 luglio 2025, a causa del mancato svolgimento dell'assemblea annuale degli azionisti per l'esercizio 2024 entro 12 mesi dalla chiusura dell'anno fiscale al 30 giugno 2024.

L'azienda dispone di 45 giorni di calendario per presentare un piano di rimedio; se Nasdaq lo accetta, Renovaro potrebbe ottenere una proroga fino al 29 dicembre 2025 per tornare in conformità. Fino ad allora, le azioni continueranno a essere negoziate sul Nasdaq. La mancata presentazione di un piano accettabile o il mancato svolgimento dell'assemblea entro la scadenza potrebbe comportare la delisting.

La direzione afferma di stare "lavorando con impegno" per preparare il piano e programmare l'assemblea "il prima possibile". Non sono stati divulgati altri dati operativi o finanziari.

Renovaro Inc. (Nasdaq: RENB) informó en un formulario 8-K que recibió una notificación de incumplimiento según la Regla de Cotización Nasdaq 5620(a) el 7 de julio de 2025 por no haber celebrado la junta anual de accionistas del año fiscal 2024 dentro de los 12 meses posteriores al cierre fiscal del 30 de junio de 2024.

La compañía tiene 45 días calendario para presentar un plan de remediación; si Nasdaq lo acepta, Renovaro podría obtener una prórroga hasta el 29 de diciembre de 2025 para volver a cumplir. Hasta entonces, las acciones seguirán cotizando en Nasdaq. No presentar un plan aceptable o no celebrar la junta antes del plazo podría resultar en la exclusión de la cotización.

La dirección declara que está "trabajando diligentemente" para preparar el plan y programar la junta "tan pronto como sea posible". No se divulgaron otros datos operativos o financieros.

Renovaro Inc. (나스닥: RENB)는 2025년 7월 7일 나스닥 상장 규칙 5620(a) 위반 통지를 8-K 보고서에서 공개했습니다. 이는 2024 회계연도 연례 주주총회를 2024년 6월 30일 회계연도 종료일로부터 12개월 이내에 개최하지 못했기 때문입니다.

회사는 45일(달력 기준) 이내에 시정 계획을 제출해야 하며, 나스닥이 이를 승인하면 Renovaro는 2025년 12월 29일까지 준수 상태를 회복할 수 있는 연장 기간을 받을 수 있습니다. 그때까지 주식은 계속 나스닥에서 거래됩니다. 수용 가능한 계획을 제출하지 않거나 기한 내에 총회를 개최하지 못하면 상장 폐지될 수 있습니다.

경영진은 "최대한 신속히" 계획을 준비하고 총회를 개최하기 위해 "열심히 노력하고 있다"고 밝혔습니다. 다른 운영 또는 재무 지표는 공개되지 않았습니다.

Renovaro Inc. (Nasdaq : RENB) a révélé dans un formulaire 8-K avoir reçu un avis de manquement selon la règle de cotation Nasdaq 5620(a) le 7 juillet 2025, pour ne pas avoir tenu son assemblée annuelle des actionnaires de l'exercice 2024 dans les 12 mois suivant la clôture de l'exercice au 30 juin 2024.

La société dispose de 45 jours calendaires pour soumettre un plan de remédiation ; si Nasdaq l'accepte, Renovaro pourrait obtenir une prolongation jusqu'au 29 décembre 2025 pour se remettre en conformité. D'ici là, l'action continuera à être négociée sur le Nasdaq. Le défaut de déposer un plan acceptable ou de tenir l'assemblée avant la date limite pourrait entraîner une radiation.

La direction déclare travailler "diligemment" à la préparation du plan et à la programmation de l'assemblée "dès que possible". Aucune autre donnée opérationnelle ou financière n'a été divulguée.

Renovaro Inc. (Nasdaq: RENB) gab in einem 8-K-Bericht bekannt, dass es am 7. Juli 2025 eine Nasdaq-Listing-Regel 5620(a) Mängelmitteilung erhalten hat, weil die Hauptversammlung für das Geschäftsjahr 2024 nicht innerhalb von 12 Monaten nach dem 30. Juni 2024 abgehalten wurde.

Das Unternehmen hat 45 Kalendertage, um einen Abhilfplan einzureichen; wenn Nasdaq diesen akzeptiert, könnte Renovaro eine Verlängerung bis zum 29. Dezember 2025 erhalten, um die Konformität wiederherzustellen. Bis dahin wird die Aktie weiterhin an der Nasdaq gehandelt. Das Versäumnis, einen akzeptablen Plan einzureichen oder die Versammlung fristgerecht abzuhalten, könnte zur Delistung führen.

Das Management erklärt, man arbeite "mit Hochdruck" daran, den Plan vorzubereiten und die Versammlung "so bald wie möglich" anzusetzen. Weitere operative oder finanzielle Kennzahlen wurden nicht veröffentlicht.

Positive
  • Listing remains active; Nasdaq will allow trading while Renovaro submits its compliance plan.
  • Extension potential up to 29 December 2025 provides ample time to rectify the issue.
Negative
  • Nasdaq non-compliance notice introduces risk of delisting if obligations are not met.
  • Governance oversight in failing to hold an annual meeting may weaken investor confidence and proxy-advisory assessments.

Insights

TL;DR — Governance lapse raises delisting risk, modest negative near-term sentiment.

Receiving a Rule 5620(a) notice is a formal warning rather than an immediate trading halt, yet it highlights a governance failure that can erode investor confidence and widen the firm’s risk premium. Renovaro retains listing status while it drafts a compliance plan, but the 45-day window and potential December 2025 deadline compress management’s timeline. Historically, most issuers resolve this type of deficiency, so the probability of ultimate delisting appears low, yet the disclosure may pressure the share price until a meeting date is announced.

TL;DR — Easily correctable compliance miss, but signals board process weakness.

The deficiency stems from not scheduling a routine annual meeting—an avoidable oversight that suggests gaps in board calendaring and investor-relations processes. Remediation requires limited resources: setting a record date, mailing proxies and convening shareholders. Nevertheless, regulators and institutional investors view timely meetings as a baseline governance standard; repeated lapses could trigger voting repercussions. Monitoring follow-through on the stated intention to hold the meeting will be key for governance-focused funds.

Renovaro Inc. (Nasdaq: RENB) ha comunicato tramite un modulo 8-K di aver ricevuto il notifica di carenza secondo la Regola di Quotazione Nasdaq 5620(a) il 7 luglio 2025, a causa del mancato svolgimento dell'assemblea annuale degli azionisti per l'esercizio 2024 entro 12 mesi dalla chiusura dell'anno fiscale al 30 giugno 2024.

L'azienda dispone di 45 giorni di calendario per presentare un piano di rimedio; se Nasdaq lo accetta, Renovaro potrebbe ottenere una proroga fino al 29 dicembre 2025 per tornare in conformità. Fino ad allora, le azioni continueranno a essere negoziate sul Nasdaq. La mancata presentazione di un piano accettabile o il mancato svolgimento dell'assemblea entro la scadenza potrebbe comportare la delisting.

La direzione afferma di stare "lavorando con impegno" per preparare il piano e programmare l'assemblea "il prima possibile". Non sono stati divulgati altri dati operativi o finanziari.

Renovaro Inc. (Nasdaq: RENB) informó en un formulario 8-K que recibió una notificación de incumplimiento según la Regla de Cotización Nasdaq 5620(a) el 7 de julio de 2025 por no haber celebrado la junta anual de accionistas del año fiscal 2024 dentro de los 12 meses posteriores al cierre fiscal del 30 de junio de 2024.

La compañía tiene 45 días calendario para presentar un plan de remediación; si Nasdaq lo acepta, Renovaro podría obtener una prórroga hasta el 29 de diciembre de 2025 para volver a cumplir. Hasta entonces, las acciones seguirán cotizando en Nasdaq. No presentar un plan aceptable o no celebrar la junta antes del plazo podría resultar en la exclusión de la cotización.

La dirección declara que está "trabajando diligentemente" para preparar el plan y programar la junta "tan pronto como sea posible". No se divulgaron otros datos operativos o financieros.

Renovaro Inc. (나스닥: RENB)는 2025년 7월 7일 나스닥 상장 규칙 5620(a) 위반 통지를 8-K 보고서에서 공개했습니다. 이는 2024 회계연도 연례 주주총회를 2024년 6월 30일 회계연도 종료일로부터 12개월 이내에 개최하지 못했기 때문입니다.

회사는 45일(달력 기준) 이내에 시정 계획을 제출해야 하며, 나스닥이 이를 승인하면 Renovaro는 2025년 12월 29일까지 준수 상태를 회복할 수 있는 연장 기간을 받을 수 있습니다. 그때까지 주식은 계속 나스닥에서 거래됩니다. 수용 가능한 계획을 제출하지 않거나 기한 내에 총회를 개최하지 못하면 상장 폐지될 수 있습니다.

경영진은 "최대한 신속히" 계획을 준비하고 총회를 개최하기 위해 "열심히 노력하고 있다"고 밝혔습니다. 다른 운영 또는 재무 지표는 공개되지 않았습니다.

Renovaro Inc. (Nasdaq : RENB) a révélé dans un formulaire 8-K avoir reçu un avis de manquement selon la règle de cotation Nasdaq 5620(a) le 7 juillet 2025, pour ne pas avoir tenu son assemblée annuelle des actionnaires de l'exercice 2024 dans les 12 mois suivant la clôture de l'exercice au 30 juin 2024.

La société dispose de 45 jours calendaires pour soumettre un plan de remédiation ; si Nasdaq l'accepte, Renovaro pourrait obtenir une prolongation jusqu'au 29 décembre 2025 pour se remettre en conformité. D'ici là, l'action continuera à être négociée sur le Nasdaq. Le défaut de déposer un plan acceptable ou de tenir l'assemblée avant la date limite pourrait entraîner une radiation.

La direction déclare travailler "diligemment" à la préparation du plan et à la programmation de l'assemblée "dès que possible". Aucune autre donnée opérationnelle ou financière n'a été divulguée.

Renovaro Inc. (Nasdaq: RENB) gab in einem 8-K-Bericht bekannt, dass es am 7. Juli 2025 eine Nasdaq-Listing-Regel 5620(a) Mängelmitteilung erhalten hat, weil die Hauptversammlung für das Geschäftsjahr 2024 nicht innerhalb von 12 Monaten nach dem 30. Juni 2024 abgehalten wurde.

Das Unternehmen hat 45 Kalendertage, um einen Abhilfplan einzureichen; wenn Nasdaq diesen akzeptiert, könnte Renovaro eine Verlängerung bis zum 29. Dezember 2025 erhalten, um die Konformität wiederherzustellen. Bis dahin wird die Aktie weiterhin an der Nasdaq gehandelt. Das Versäumnis, einen akzeptablen Plan einzureichen oder die Versammlung fristgerecht abzuhalten, könnte zur Delistung führen.

Das Management erklärt, man arbeite "mit Hochdruck" daran, den Plan vorzubereiten und die Versammlung "so bald wie möglich" anzusetzen. Weitere operative oder finanzielle Kennzahlen wurden nicht veröffentlicht.

false 0001527728 0001527728 2025-07-14 2025-07-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 14, 2025

 

RENOVARO INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-38751   45-2259340
(State or other jurisdiction   (Commission File Number)   (I.R.S. Employer
of incorporation)       Identification No.)

 

2080 Century Park East, Suite 906

Los Angeles, CA 90067

 (Address of principal executive offices)

 

+1 (305) 918-1980

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol   Name of Each Exchange on Which Registered
Common Stock, par value $0.0001 per share   RENB   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

 

On July 7, 2025, Renovaro Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is no longer in compliance with Nasdaq Listing Rule 5620(a), which requires that listed companies hold an annual meeting of shareholders no later than one year after the end of their fiscal year.

 

The Company did not hold its annual meeting of shareholders within twelve months of the end of its fiscal year ended June 30, 2024, and therefore did not satisfy this requirement. Pursuant to Nasdaq Listing Rule 5810(c)(2)(G), the Company has 45 calendar days from the date of the Notice to submit a plan to regain compliance. If Nasdaq accepts the Company’s plan, Nasdaq may grant the Company an extension of up to 180 calendar days from the fiscal year end, or until December 29, 2025, to regain compliance.

 

The Company is working diligently to submit a plan of compliance within the required timeframe and intends to hold its annual meeting of shareholders as soon as practicable to regain compliance with Nasdaq’s continued listing standards.

 

This notice does not immediately affect the listing or trading of the Company’s common stock on Nasdaq. However, if the Company fails to timely submit a compliance plan or if Nasdaq does not accept the Company’s plan, the Company’s common stock may be subject to delisting.

 

The Company intends to monitor its compliance with the applicable Nasdaq Listing Rules and will take all necessary steps to maintain its Nasdaq listing.

 

Forward – Looking Statements

This Current Report on Form 8-K contains forward-looking statements that involve risks and uncertainties, including statements regarding the Company’s intent to submit a compliance plan and hold its annual meeting. Actual results may differ materially from the results predicted or implied. These forward-looking statements are subject to a number of risks and uncertainties, including but not limited to the Company’s ability to meet Nasdaq’s requirements, the Company’s financial position, and other factors disclosed in the Company’s filings with the Securities and Exchange Commission.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  RENOVARO INC.
   
  By: /s/ David Weinstein
    Name: David Weinstein
Title: Chief Executive Officer

 

Date: July 14, 2025 

 

 

 

FAQ

Why did Renovaro (RENB) receive a Nasdaq notice?

The company failed to hold its FY 2024 annual shareholder meeting within 12 months, violating Nasdaq Rule 5620(a).

Does the notice immediately delist RENB shares?

No. The stock continues to trade; delisting would occur only if Renovaro misses future compliance deadlines.

How long does Renovaro have to respond to Nasdaq?

Renovaro must submit a compliance plan within 45 calendar days of the 7 July 2025 notice.

What is the final deadline to regain compliance?

If Nasdaq accepts the plan, Renovaro has until 29 December 2025 to hold the shareholder meeting.

What actions is Renovaro taking to resolve the issue?

Management says it is "working diligently" to file the plan and schedule the annual meeting as soon as practicable.
Renovaro

NASDAQ:RENB

RENB Rankings

RENB Latest News

RENB Latest SEC Filings

RENB Stock Data

51.03M
90.75M
50.1%
13.71%
3.46%
Biotechnology
Pharmaceutical Preparations
Link
United States
SUITE 906 LOS ANGELES